|

SCTB35 injection Clinical Trials

3 actively recruiting trials

▲ +2 trials since August 2026

Pipeline

Phase 3: 2Phase 1/2: 1

Top Sponsors

  • Sinocelltech Ltd.3

Indications

  • Cancer2
  • System Lupus Erythematosus1
  • Lupus1
  • Follicular Lymphoma ( FL)1
  • DLBCL - Diffuse Large B Cell Lymphoma1

Other3 trials

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Phase 1/2
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 3
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.